Login

Hendrik Bischof from HUBER+SUHNER discusses his role in Group Strategy and M&A and his experiences working at the company. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Chesapeake Gold's Matatus Project: Advancing a World-Class Gold-Silver Deposit with Strategic Development
00:10:00
An interview with Aferian plc CEO Donald McGarva | Donald McGarva, CEO, Aferian PLCDWJ:BER
00:10:00
SUPERIOR SAFETY PROFILE WITH MINIMAL SIDE EFFECTS|JOHN CAVAN,CEO,ContraVir Pharmaceuticals Inc
00:00:00
Interview with Alan Clarke, CEO Abano Healthcare Limited
00:10:00
Wilson Romanini Discusses Vittia’s IPO, Career Journey, and Future Prospects | Wilson Romanini, CEO, Vittia Fertilizantes e Biológicos SA.
00:10:00
We strive to excel in everything we do.|Abrielle Rosenthal, Chief Sustainability Officer,TowerBrook Capital Partners, L.P.
00:10:00
IMSHealth 2024: Education Management Solutions Unveils Training in Motion. Interview Highlights: Matt Merino, CEO of Education Management corporation.
00:10:00
Star Royalties: Innovating the Royalty Space with Carbon Negative Gold Royalties
00:10:00
Scaling profitable businesses through insurance distribution, technology|Ramin Niroumand,Founder and Managing Partner,embedded/capital
00:10:00
Richard Salmen Joins FIC: Elevating Financial Freedom in 2018 | Dan Danford - FOUNDER AND CHAIRMAN OF THE BOARD of Family Investment Center
00:10:00
Mark D. Harris on Crafting Persuasive Appellate Briefs | Mark D. Harris - Partner, Proskauer Rose LLP
00:10:00
Understanding Retirement Feasibility with Beacon Financial Strategies | Chip Hymiller, Founder , Beacon Financial Strategies.

© 2017 - Neuhu+